The results of our combined efforts to generate a reversible, Stat5-induced leukemia model indicate that this signal transducer appears to be a rather weak oncogene that requires additional, cancer-initiating mutations to trigger a malignant phenotype. This evidence concerns the gene STAT5B and cancer.